市場調查報告書
商品編碼
1497807
全球天冬醯胺市場:按類型、應用-預測(2024-2030)Asparagine Market by Type (Asparagine Anhydrous, Asparagine Monohydrate), Application (Food & Beverage, Pharmaceutical) - Global Forecast 2024-2030 |
※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。
預計2023年全球天門冬胺酸市場規模將達118.1億美元,2024年將達124億美元,複合年成長率為5.29%,2030年將達169.6億美元。
天冬醯胺是一種胺基酸,在蛋白質生物合成中發揮重要作用。它是大腦發育和功能的重要組成部分,也是神經傳導物質的前體。天冬醯胺市場涵蓋生物技術、食品和飲料、製藥和動物飼料等各個行業,展示了其廣泛的用途。分析市場需要深入了解其應用、最終用途、市場規模、成長機會因素、限制、創新潛力等。人們對營養食品健康意識的增強以及製藥業研發投資的增加正在推動市場的成長。食品飲料產業不斷的技術創新也在推動市場發展。原料價格的波動、有關天冬醯胺使用的嚴格法規和標準限制了市場的成長。含天冬醯胺的新型藥物製劑的市場開拓、精準醫療和標靶治療的興起預計將為市場提供機會。
主要市場統計 | |
---|---|
基準年[2023] | 118.1億美元 |
預測年份 [2024] | 124億美元 |
預測年份 [2030] | 169.6億美元 |
複合年成長率(%) | 5.29% |
區域洞察
美洲天冬醯胺市場的特點是北美先進的生物技術領域。美國生產和消費天冬醯胺,主要用於製藥和食品工業。南美市場正在興起,巴西食品添加劑應用和研究對天冬醯胺的需求不斷增加。北美有關食品添加劑和臨床營養的嚴格法規正在推動對高純度天冬醯胺的需求。在以中國、日本和印度主導的亞太地區,由於製藥、食品以及食品和飲料行業的成長,天冬醯胺市場正在迅速擴大。中國大規模的生產能力使其成為國內外天冬醯胺的重要供應國。該地區正在經歷營養和保健食品行業的成長,推動了對天冬醯胺等氨基酸的需求。不斷變化的監管環境和不斷增強的消費者健康意識正在進一步塑造市場動態。在歐洲、中東和非洲,歐洲引領天門冬胺酸的成熟市場,特別是在製藥和食品產業。人口的穩定老化導致該地區對含天冬醯胺的營養食品和腸外營養的巨大需求。中東和非洲市場有待開拓,但由於健康意識的提高和飲食習慣的改變,具有成長潛力。
FPNV定位矩陣
FPNV 定位矩陣對於評估供應商在天門冬胺酸市場的定位至關重要。此矩陣提供了對供應商的全面評估,並檢驗了與業務策略和產品滿意度相關的關鍵指標。這種詳細的評估使用戶能夠根據自己的要求做出明智的決定。根據評估結果,供應商被分為代表其成功程度的四個像限:前沿(F)、探路者(P)、利基(N)和重要(V)。
市場佔有率分析
市場佔有率分析是一種綜合工具,可以對天冬醯胺市場供應商的現狀進行深入而詳細的評估。透過仔細比較和分析供應商的貢獻,您可以更深入地了解每個供應商的績效以及他們在爭奪市場佔有率時面臨的挑戰。這些貢獻包括整體收益、客戶群和其他重要指標。此外,該分析還提供了對該領域競爭性質的寶貴見解,包括累積研究期、片段化優勢和合併特徵等因素。有了這些詳細資訊,供應商可以做出更明智的決策並製定有效的策略,以在市場競爭中保持領先地位。
策略分析與建議
策略分析對於尋求在全球市場站穩腳跟的組織至關重要。對當前天冬醯胺市場地位的全面評估使公司能夠做出符合其長期願望的明智決策。此關鍵評估涉及對組織的資源、能力和整體績效進行徹底分析,以確定核心優勢和需要改進的領域。
[183 Pages Report] The Asparagine Market size was estimated at USD 11.81 billion in 2023 and expected to reach USD 12.40 billion in 2024, at a CAGR 5.29% to reach USD 16.96 billion by 2030.
Asparagine, an amino acid, plays a fundamental role in the biosynthesis of proteins. It is an essential component required for the development and functioning of the brain and is a precursor to neurotransmitters. The asparagine market spans various industries, including biotechnology, food and beverage, pharmaceuticals, and animal feed, showcasing its broad spectrum of utilizations. Analyzing the market requires insights into its applications, end-uses, market scope, growth opportunity factors, limitations, and potential areas of innovation. Rising health consciousness for dietary supplements and increased investment in R&D in the pharmaceutical industry are driving the market growth. Ongoing innovations in the food and beverage industry are also propelling the market. Fluctuations in the prices of raw materials and stringent regulations and standards regarding the use of asparagine are restricting market growth. The development of novel pharmaceutical formulations containing asparagine and the rise in precision medicine and targeted therapies are expected to create opportunities in the market.
KEY MARKET STATISTICS | |
---|---|
Base Year [2023] | USD 11.81 billion |
Estimated Year [2024] | USD 12.40 billion |
Forecast Year [2030] | USD 16.96 billion |
CAGR (%) | 5.29% |
Regional Insights
The Asparagine market in the Americas is characterized by advanced biotechnology sectors, particularly in North America. The United States produces and consumes Asparagine, predominantly for the pharmaceuticals and food industries. South America's market is emerging, with Brazil showing increasing demand for Asparagine in food additive applications and research. Stringent regulations on North American food additives and clinical nutrition bolster the demand for high-purity Asparagine. The Asia-Pacific, led by China, Japan, and India, has a rapidly expanding asparagine market due to its growing pharmaceutical, food, and beverage industries. China's large-scale manufacturing capabilities make it a significant supplier of Asparagine domestically and globally. The region is witnessing growth in nutrition and health supplement sectors, driving the need for amino acids such as Asparagine. The evolving regulatory landscape and increasing consumer health consciousness further shape the market dynamics. In EMEA, Europe leads with a mature market for Asparagine, particularly within the pharmaceutical and nutraceutical industries. The steadily aging population contributes to the region's significant demand for dietary supplements and parenteral nutrition, which includes Asparagine. The market needs to be developed in the Middle East and Africa but presents potential for growth with rising health awareness and changing dietary habits.
Market Insights
The market dynamics represent an ever-changing landscape of the Asparagine Market by providing actionable insights into factors, including supply and demand levels. Accounting for these factors helps design strategies, make investments, and formulate developments to capitalize on future opportunities. In addition, these factors assist in avoiding potential pitfalls related to political, geographical, technical, social, and economic conditions, highlighting consumer behaviors and influencing manufacturing costs and purchasing decisions.
FPNV Positioning Matrix
The FPNV positioning matrix is essential in evaluating the market positioning of the vendors in the Asparagine Market. This matrix offers a comprehensive assessment of vendors, examining critical metrics related to business strategy and product satisfaction. This in-depth assessment empowers users to make well-informed decisions aligned with their requirements. Based on the evaluation, the vendors are then categorized into four distinct quadrants representing varying levels of success, namely Forefront (F), Pathfinder (P), Niche (N), or Vital (V).
Market Share Analysis
The market share analysis is a comprehensive tool that provides an insightful and in-depth assessment of the current state of vendors in the Asparagine Market. By meticulously comparing and analyzing vendor contributions, companies are offered a greater understanding of their performance and the challenges they face when competing for market share. These contributions include overall revenue, customer base, and other vital metrics. Additionally, this analysis provides valuable insights into the competitive nature of the sector, including factors such as accumulation, fragmentation dominance, and amalgamation traits observed over the base year period studied. With these illustrative details, vendors can make more informed decisions and devise effective strategies to gain a competitive edge in the market.
Recent Developments
Jazz Pharmaceuticals Receives European Commission Approval for Enrylaze (a recombinant Erwinia asparaginase or crisantaspase) for the Treatment of Acute Lymphoblastic Leukemia and Lymphoblastic Lymphoma
Jazz Pharmaceuticals plc has announced a significant development with the European Commission's approval of Enrylaze (JZP458), a recombinant Erwinia asparaginase, under the brand name Rylaze in the U.S. and Canada. This endorsement authorizes Enrylaze for use within multi-agent chemotherapy treatments for acute lymphoblastic leukemia (ALL) and lymphoblastic lymphoma (LBL) for those aged one month and older who are intolerant and have an inadequate response to E. coli-derived asparaginases. [Published On: 2023-09-21]
Kaimisi New Material and Bicells to build 2,000 t per year L-asparagine project and 100 t per year GABA project
Shandong Kaimisi New Material Technology Co., Ltd. has announced the successful publication of their Environmental Impact report, approved on October 11 by the Dongying Municipal Ecological Environment Bureau, for a pioneering L-asparagine production project using biofermentation. The project, situated in Dongying City's Economic Development Zone, sees an investment of approximately USD 28.17 million aimed at erecting a state-of-the-art facility capable of yielding 2,000 tons per annum (t/a) of this essential amino acid, known for its extensive applications across the food, medical, and environmental protection industries. [Published On: 2022-01-11]
Strategy Analysis & Recommendation
The strategic analysis is essential for organizations seeking a solid foothold in the global marketplace. Companies are better positioned to make informed decisions that align with their long-term aspirations by thoroughly evaluating their current standing in the Asparagine Market. This critical assessment involves a thorough analysis of the organization's resources, capabilities, and overall performance to identify its core strengths and areas for improvement.
Key Company Profiles
The report delves into recent significant developments in the Asparagine Market, highlighting leading vendors and their innovative profiles. These include BioVendor Group, Creative Enzymes, Duchefa Biochemie B.V., Jazz Pharmaceuticals, Inc., LGC Limited, medac GmbH, Merck KGaA, MP Biomedicals, LLC, Porton Biopharma Limited, Taj Pharmaceuticals Ltd., Tokyo Chemical Industry (India) Pvt. Ltd., and VWR International, LLC.
Market Segmentation & Coverage